[埃罗省肿瘤泌尿专科登记处（RHESOU）：法国首个肿瘤泌尿专科登记处。一年经验]
[RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].
作者信息
Trouche-Sabatier S G, Rebillard X, Iborra F, Azria D, Daures J-P, Poinas G, Abdo N, Delbos O, Gevorgyan A, Marchal S, Guillon R, Millet I, Lamy P-J, Lauche O, Reis-Borges R, Serre I, Topart D, Tretarre B
机构信息
Registre des tumeurs de l'Hérault, Montpellier, France.
Comité de pilotage, Montpellier, France; Clinique Beau Soleil, Montpellier, France.
出版信息
Prog Urol. 2020 Dec;30(16):1038-1044. doi: 10.1016/j.purol.2020.09.015. Epub 2020 Oct 1.
PURPOSE
In 2016, the Herault tumor registry collected 1961cancers in urology (21.4 % from all Herault cancers this year). RHESOU was created to complete RTH' data with specific parameters in onco-urology. The aim of this study is to describe RHESOU and to give some examples with our first results.
MATERIAL AND METHODS
In November 2018, RHESOU (Registry HErault Specialised in Onco-Urology) was founded with the same registry recommendations. It collects specific oncologic parameters and also complete RTH's data. For each urological cancer, a specific survey with different choices was performed to collect a maximum of data which could be present in patients' file. These surveys were used for urological cancers cases that live in Herault in 2017.
RESULTS
In 2017, we collected 970 prostate cancers, 581 bladder cancers, 212 kidney cancers, 51 upper excretory tract cancers, 28 testicle cancers and 9 penil cancers. Our urological data collection gives many possibilities to create many requests for detailed analysis in urological cancers. In this article, we reported data from kidney, bladder and prostate cancers.
CONCLUSIONS
RHESOU is a new tool opened to the different urologic corporations (urologists, pathologists, oncologists, radiotherapists, radiologists) that permits an overview in urological cancers in Herault. Finally, one important aim is that this tool will be adapted when new treatments or new important parameters appear in the years ahead.
LEVEL OF EVIDENCE
目的
2016年，埃罗省肿瘤登记处收集了1961例泌尿外科癌症病例（占该年埃罗省所有癌症病例的21.4%）。创建RHESOU是为了用肿瘤泌尿学的特定参数完善RTH的数据。本研究的目的是描述RHESOU并给出一些初步结果示例。
材料与方法
2018年11月，RHESOU（埃罗省肿瘤泌尿学专科登记处）依据相同的登记建议成立。它收集特定的肿瘤学参数并完善RTH的数据。对于每例泌尿外科癌症，进行了一项有不同选项的特定调查，以收集患者病历中可能存在的最多数据。这些调查用于2017年居住在埃罗省的泌尿外科癌症病例。
结果
2017年，我们收集了970例前列腺癌、581例膀胱癌、212例肾癌、51例上尿路癌、28例睾丸癌和9例阴茎癌。我们的泌尿外科数据收集为开展许多泌尿外科癌症详细分析的请求提供了诸多可能性。在本文中，我们报告了肾癌、膀胱癌和前列腺癌的数据。
结论
RHESOU是一个面向不同泌尿外科机构（泌尿外科医生、病理学家、肿瘤学家、放射治疗师、放射科医生）开放的新工具，可对埃罗省的泌尿外科癌症进行全面了解。最后，一个重要目标是在未来几年出现新治疗方法或新的重要参数时，该工具将进行调整。
证据级别
3级。
Zotero 插件